Inhibition of glucose metabolism prevents glycosylation of the glutamine transporter ASCT2 and promotes compensatory LAT1 upregulation in leukemia cells

SUPPLEMENTARY FIGURES Supplementary
: ASCT2 silencing does not alter K-562 cell growth and DMOX does not completely compensate for glutamine deprivation. A. Representative immunoblot depicting ASCT2 silencing upon K-562 cell exposure to dedicated siRNA. Immunoblot was repeated two times with similar results; β-actin immunobloting was used as loading control. B. Inhibition of K-562 cell growth after 48 hours post-treatment with ASCT2 siRNA (**P<0.01, n=3). C. Cell-permeable dimethyloxoglutarate (DMOX) unmasks the contribution of non-metabolized glutamine to K-562 cell growth.
